Yale School of Medicine
M

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does Not Whisper, We Just Don't Listen

By Yale School of Medicine FEATURING Mary Jane Minkin, Elena Ratner
By Yale School of Medicine FEATURING Mary Jane Minkin, Elena Ratner
4,711 views
June 27, 2022
15 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
17:39
Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin
27:04
Fengting Yan

Cancer Screening Molecular Tools

53:42
PleXus Communications

Managing Women's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
18:49
Yale School of Medicine

Menopause and Hot Flashes: What Medications are Available?

Feat. M. Minkin
06:50
Fengting Yan

Year in Review: Ovarian Cancer

11:15
Total Health

2024 Updates in Ovarian Cancer

Feat. T. Tillmanns
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

28:11
OncoAlert

Ovarian Cancer: Setting a New Standard of Care

Feat. M. Raza Mirza
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

14:05
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…

Feat. A. Clamp
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

11:37
UCLA Health

Recurrent Cervical Cancer Updates

Feat. R. Salani
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
08:37
Fred Hutchinson Cancer Center

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Feat. K. Banda